NEDD4L-induced ubiquitination mediating UBE2T degradation inhibits progression of lung adenocarcinoma via PI3K-AKT signaling

被引:0
|
作者
Yongbing Chen
Haihua Hong
Qingqing Wang
Junqiang Li
Wenfeng Zhang
Tingting Chen
Pu Li
机构
[1] Zhejiang University School of Medicine First Affiliated Hospital,Department of Respiratory Medicine, Beilun Branch
[2] Zhejiang University School of Medicine First Affiliated Hospital,Department of Pathology, Beilun Branch
[3] Nanchang University,Department of Infectious Disease, The First Affiliated Hospital
[4] Third Military Medical University (Army Medical University),Department of Urology, The Second Affiliated Hospital
[5] Nanchang University,State Drug Clinical Trial Agency, The First Affiliated Hospital
来源
关键词
Lung adenocarcinoma; NEDD4L; UBE2T; Ubiquitylation; PI3K-AKT signaling;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Thyroid hormone protects cardiomyocytes from H2O2-induced oxidative stress via the PI3K-AKT signaling pathway
    Zeng, Bin
    Liu, Lei
    Liao, Xiaoting
    Zhang, Caixia
    Ruan, Huaiyu
    EXPERIMENTAL CELL RESEARCH, 2019, 380 (02) : 205 - 215
  • [32] PLEK2 activates the PI3K/AKT signaling pathway to drive lung adenocarcinoma progression by upregulating SPC25
    Zhang, Wenqian
    Yu, Lei
    Xu, Cong
    Tang, Tian
    Cao, Jianguang
    Chen, Lei
    Pang, Xinya
    Ren, Weihao
    CELL BIOLOGY INTERNATIONAL, 2024, 48 (09) : 1285 - 1300
  • [33] ErbB2 signaling activates the Hedgehog pathway via PI3K-Akt in human esophageal adenocarcinoma: Identification of novel targets for concerted therapy concepts
    Kebenko, Maxim
    Drenckhan, Astrid
    Gros, Stephanie J.
    Juecker, Manfred
    Grabinski, Nicole
    Ewald, Florian
    Grottke, Astrid
    Schultze, Alexander
    Izbicki, Jakob R.
    Bokemeyer, Carsten
    Wellbrock, Jasmin
    Fiedler, Walter
    CELLULAR SIGNALLING, 2015, 27 (02) : 373 - 381
  • [34] Dexamethasone inhibits insulin-induced chondrogenesis of ATDC5 cells by preventing PI3K-Akt signaling and DNA binding of Runx2
    Fujita, T
    Fukuyama, R
    Enomoto, H
    Komori, T
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 93 (02) : 374 - 383
  • [35] Epigallocatechin-3-gallate inhibits adipogenesis through down-regulation of PPARγ and FAS expression mediated by PI3K-AKT signaling in 3T3-L1 cells
    Wu, Mengqing
    Liu, Dan
    Zeng, Rong
    Xian, Tao
    Lu, Yi
    Zeng, Guohua
    Sun, Zhangzetian
    Huang, Bowei
    Huang, Qiren
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 795 : 134 - 142
  • [36] STRIP2 is regulated by the transcription factor Sp1 and promotes lung adenocarcinoma progression via activating the PI3K/AKT/mTOR/MYC signaling pathway
    Pan, Junfan
    Zhang, Yuan
    He, Liu
    Wu, Yue
    Xiao, Weijin
    Zhang, Jing
    Xu, Yiquan
    GENOMICS, 2024, 116 (05)
  • [37] MicroRNA-31 Inhibits Lung Adenocarcinoma Stem-Like Cells via Down-Regulation of MET-PI3K-Akt Signaling Pathway
    Hou, Chunying
    Sun, Bo
    Jiang, Yao
    Zheng, Ji
    Yang, Nan
    Ji, Chao
    Liang, Zhen
    Shi, Jiaojiao
    Zhang, Rui
    Liu, Yanyong
    Ye, Caiying
    Zuo, Pingping
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2016, 16 (04) : 501 - 518
  • [38] Quercetin and Flavonoids from Cuscuta chinensis Lam. Inhibit Tripterygium Glycoside-Induced Premature Ovarian Failure Progression via PI3K-AKT Signaling Pathway
    Huang, Changsheng
    Ning, Yan
    Guan, Yancheng
    Luo, Mingli
    Tan, Ning
    Luo, Shicun
    He, Shoudi
    Li, Deyu
    PHARMACOGNOSY MAGAZINE, 2021, 17 (75) : 475 - 481
  • [39] Suberosin Alleviates Thiazolidinedione-Induced Cardiomyopathy in Diabetic Rats by Inhibiting Ferroptosis via Modulation of ACSL4-LPCAT3 and PI3K-AKT Signaling Pathways
    Shabnoor Iqbal
    Farhat Jabeen
    Ivan Kahwa
    Timothy Omara
    Cardiovascular Toxicology, 2023, 23 : 295 - 304
  • [40] Suberosin Alleviates Thiazolidinedione-Induced Cardiomyopathy in Diabetic Rats by Inhibiting Ferroptosis via Modulation of ACSL4-LPCAT3 and PI3K-AKT Signaling Pathways
    Iqbal, Shabnoor
    Jabeen, Farhat
    Kahwa, Ivan
    Omara, Timothy
    CARDIOVASCULAR TOXICOLOGY, 2023, 23 (9-10) : 295 - 304